EGFR and Alzheimer disease: Thus, aberrant EGFR signaling may be associated with impaired skin barrier function and the maintenance of chronic inflammation in AD patients.[56,57] PTGS2, also known as COX-2, is an enzyme that promotes the synthesis of prostaglandins, which can exacerbate skin inflammation.